Skip to search formSkip to main contentSkip to account menu

HPE 101

Known as: HPE-101 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Effects of HPE-101, a skin penetration enhancer, on human erythrocyte membranes.
1996
1996
Optimization effects of hydroxypropyl-β-cyclodextrin in combination with nasal absorption enhancer HPE-101
1994
1994
In vivo microdialysis for the transdermal absorption of valproate in rats.
The suitability of sampling via microdialysis for a lipophilic drug, valproate (VPA), was evaluated by the elimination rate… 
1994
1994
Application of in Vivo Microdialysis to Transdermal Absorption of Methotrexate in Rats
Microdialysis was applied to determine the in vivo transdermal absorption of methotrexate (MTX) in rats with or without a new… 
1993
1993
Further Evaluation of a New Penetration Enhancer, HPE‐101
Abstract— The penetration enhancer, 1‐[2‐(decylthio)ethyl]azacyclopentan‐2‐one (HPE‐101), significantly enhanced the excretion of… 
1992
1992
Evaluation of a new penetration enhancer 1-[2-(decylthio)ethyl]azacyclopentan-2-one (HPE-101).
A new compound, 1-[2-(decylthio)ethyl]azacyclopentan-2-one (HPE-101) was synthesized, and its skin penetration enhancing activity… 
1992
1992
COMBINED USE OF CYCLODEXTRIN DERIVATIVES AND PENETRATION ENHANCER HPE-101 IN TRANSDERMAL DELIVERY OF PROSTAGLANDIN E_1
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)